CVS HEALTH CORPORATION

World Rank (Jan-07-2022)
99
Market Cap (Jan-07-2022)
137.540 Billion USD
World Rank (Sep-01-2021)
138
Market Cap (Sep-01-2021)
114.000 Billion USD
World Rank (Jan-01-2021)
154
Market Cap (Jan-01-2021)
89.399 Billion USD
World Rank (Jan-2020)
119
Market Cap (Jan 1st 2020)
98.693 Billion USD
Annual Revenue in USD
292,110 Million USD
Annual Net Income in USD
7,910 Million USD
Annual Results for Year Ending
Dec-2021
Total Assets in USD
233,000 Million USD
Total Liabilities in USD
157,920 Million USD
Total Equity in USD
75,075 Million USD
Balance Sheet Summary for Period ending
Dec-2021
Headquarters Region / City
Rhode Island
Headquarters Country
USA
Headquarters Sub Region
Northern America
Headquarters Continent
Americas
Company Business
Healthcare
Pharmacy
Healthcare Service
Retail
HealthCare Products
Insurance
Stock Category
S&P 500
Stock Exchange
NYSE
Company Rank in Country in 2022
Company Rank in USA in 2022 is 58
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 88
Rank in Country (Jan-2020)
Rank in USA in 2020 is 67
Number of Employees
295,000
Employee Count as on Date
As on 2021
Chairman
David W. Dorman
CEO:
Karen S. Lynch
Founders
CVS Pharmacy
CVS Caremark
Yahoo @ NYSE
Wikipedia
Company Website:
CVS Health Corporation - Healthcare - Retail Pharmacy
Founded Year
1996
Business Sector:
Top Retail Companies in USA
Top Healthcare Companies in USA
Top Healthcare Companies in S&P 500
About Company Business:

CVS Health Corporation is USA Based Healthcare Company and its services include Retail Pharmacy, Pharmacy Benefits Management, Clinical Services, Specialty Pharmacy, Digital Services. Headquarters is in USA.

As on 2020, CVS Health Corporation has 9,962 stores.

As on 2021,  CVS Health Corporation has 29,5000 employees.

CVS Health Corporation have three segments:

  • Health Care Benefits:

The Health Care Benefits segment offers a broad range of traditional, voluntary, and consumer-directed health insurance products and related services, including: 

medical, pharmacy, dental, and behavioral health plans 

medical management capabilities 

Medicare Advantage and Medicare Supplement plans n Prescription Drug Plans (PDP) 

Medicaid health care management services n health information technology products and services.

  • Pharmacy Services.

The Pharmacy Services segment provides a full range of pharmacy benefit management (PBM) solutions, including: 

plan design offerings and administration.

formulary management n retail pharmacy network management services.

mail order pharmacy.

specialty pharmacy and infusion services n clinical services n disease management services.

medical spend management.

  • Retail/Long-Term Care:

The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, and: 

provides health care services through its walk-in medical clinics.

provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19, and shingles.

conducts LTC operations, which distribute prescription drugs and provide other ancillary services to chronic care facilities and other care settings.

  • COVID-19 vaccines and 32+ million COVID-19 tests administered: 59 million.
  • Members with Aetna and Caremark: 100 million.
  • 9,000 retail locations with 1,200 walk-in clinics.
  • 4.5 million consumers visit CVS Health locations daily.
  • 2.4% overall drug trend and 5.8% specialty trend through as on 2021.
  • 4,000+ nurse practitioners and physician assistants currently employed.
  • 40 million unique digital customers.
  • 19 million virtual visits across CVS and Aetna in 2021, including 10 million behavioral health visits.

CVS Health Corporation annual revenue generated for period ending Dec-2021 was 46,385 million USD.

Split of Regional Revenue by business segment  for period ending Dec-2021:

  • Products: 203,738 million USD.
  • Premiums: 76,132 million USD.
  • Services: 11,042 million USD.
  • Net investment income: 1,199 million USD.

CVS Health Corporation  annual net income generated for period ending Dec-2021 was 7,910 million USD.

Total Assets as on Dec-2021 was 232,999 Million USD

 

 

Annual Revenue
CVS HEALTH CORPORATION Annual Revenues for December-2019 ending is 156,776 Million USD
Annual Net Income
CVS HEALTH CORPORATION Annual Net Income for December-2019 ending is 6,634 Million USD
Total Current Assets
CVS HEALTH CORPORATION Total Current Assets as on June-2020 is 62,506 Million USD
Total Assets
CVS HEALTH CORPORATION Total Assets as on June-2020 is 235,495 Million USD
Total Current Liabilities
CVS HEALTH CORPORATION Total Current Liabilities as on June-2020 is 63,694 Million USD
Total Liabilities
CVS HEALTH CORPORATION Total Liabilities as on June-2020 is 167,473 Million USD
Total Equity
CVS HEALTH CORPORATION Total Equity as on June-2020 is 68,022 Million USD
Annual Results Summary:

CVS HEALTH CORPORATION - Annual Results - Revenue and Net Profit - in Million USD:

Year - Ending Revenue Operating Income Net Income
Dec-2022 322,467 16,082 4,149
Dec-2021 292,111 14,982 7,910
Dec-2020 268,706 13,911 7,179
Dec-2019 156,776 11,987 6,634
Dec-2018 194,579 10,170 -594  (Loss)
Dec-2017 184,765 9,517 6,622
Balance Sheet Summary

CVS HEALTH CORPORATION - Balance Sheet Summary - in Million USD:

Year Ending: Total Assets Total Liabilities Total Equity
Dec-2022 228,275 156,960 71,315
Dec-2021 232,999 157,618 75,381
Dec-2020 230,715 161,326 69,389
Dec-2019 222,449 158,585 63,864
Dec-2018 196,456 138,231 58,225
Dec-2017 95,131 57,440 37,691
Dec-2016 94,462 57,632 36,830
Quarterly Results Summary:

CVS HEALTH CORPORATION - Quarterly Results - Revenue and Net Profit - in Million USD:

Quarterly Ending Total Revenue Gross Profit Operating Income Net Income
Dec-2022 83,846 13,813 3,729 2,302
Sep-2022 81,159 13,375 3,769 -3,416
Jun-2022 80,636 13,740 4,569 2,951
Mar-2022 76,826 13,366 3,490 2,312
Dec-2021 76,604 13,652 3,587 1,306
Sep-2021 73,794 12,702 3,492 1,598
Jun-2021 72,616 13,195 4,326 2,783
Mar-2021 69,097 12,499 3,577 2,223
Dec-2020 69,554 11,957 2,524 973
Sep-2020 67,056 11,720 3,249 1,224
Jun-2020 65,341 13,348 4,680 2,975
Mar-2020 66,755 12,021 3,458 2,007
Dec-2019 66,889 11,691 3,037 1,747
Institutional Investors

Top 30 Institutional Holder Names in CVS HEALTH CORPORATION as on JUN-30-2022

RANK INSTITUTIONAL HOLDER NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 VANGUARD GROUP INC 6/30/2022 114,208,329 2,342,667 2.09% $11,684,654
2 BLACKROCK INC. 6/30/2022 94,478,091 1,511,481 1.63% $9,666,053
3 CAPITAL WORLD INVESTORS 6/30/2022 58,836,048 202,627 0.35% $6,019,516
4 STATE STREET CORP 6/30/2022 58,684,310 -576,994 -0.97% $6,003,992
5 MORGAN STANLEY 6/30/2022 29,378,855 6,613,041 29.05% $3,005,751
6 CAPITAL INTERNATIONAL INVESTORS 6/30/2022 26,259,023 -1,880,475 -6.68% $2,686,561
7 JPMORGAN CHASE & CO 6/30/2022 26,118,234 2,117,597 8.82% $2,672,157
8 GEODE CAPITAL MANAGEMENT, LLC 6/30/2022 23,188,133 761,218 3.39% $2,372,378
9 BANK OF AMERICA CORP /DE/ 6/30/2022 18,244,881 741,541 4.24% $1,866,634
10 INVESCO LTD. 6/30/2022 16,756,780 -576,761 -3.33% $1,714,386
11 AMERIPRISE FINANCIAL INC 6/30/2022 15,685,087 1,262,093 8.75% $1,604,741
12 BANK OF NEW YORK MELLON CORP 6/30/2022 14,823,309 -1,205,319 -7.52% $1,516,573
13 NORTHERN TRUST CORP 6/30/2022 14,665,961 8,755 0.06% $1,500,474
14 ROYAL BANK OF CANADA 6/30/2022 13,950,495 -790,274 -5.36% $1,427,275
15 DODGE & COX 6/30/2022 13,709,717 -360,565 -2.56% $1,402,641
16 NORGES BANK 12/31/2021 13,055,500 -636,162 -4.65% $1,335,708
17 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 6/30/2022 11,675,191 -24,093 -0.21% $1,194,489
18 FMR LLC 6/30/2022 10,643,405 -1,273,593 -10.69% $1,088,927
19 LEGAL & GENERAL GROUP PLC 6/30/2022 10,321,160 220,516 2.18% $1,055,958
20 DIMENSIONAL FUND ADVISORS LP 6/30/2022 10,310,845 -764,636 -6.90% $1,054,903
21 PRICE T ROWE ASSOCIATES INC /MD/ 6/30/2022 9,811,248 -384,640 -3.77% $1,003,789
22 NORDEA INVESTMENT MANAGEMENT AB 6/30/2022 9,680,490 2,697,382 38.63% $990,411
23 VERITAS ASSET MANAGEMENT LLP 6/30/2022 8,526,923 -6,150,861 -41.91% $872,389
24 WELLINGTON MANAGEMENT GROUP LLP 6/30/2022 8,361,989 -155,228 -1.82% $855,515
25 WELLS FARGO & COMPANY/MN 6/30/2022 8,358,616 -664,451 -7.36% $855,170
26 GOLDMAN SACHS GROUP INC 6/30/2022 8,140,957 94,807 1.18% $832,901
27 FRANKLIN RESOURCES INC 6/30/2022 8,108,609 -687,319 -7.81% $829,592
28 UBS GROUP AG 6/30/2022 7,321,307 198,472 2.79% $749,043
29 BOSTON PARTNERS 6/30/2022 6,957,150 200,337 2.97% $711,786
30 MACQUARIE GROUP LTD 6/30/2022 6,382,746 -150,759 -2.31% $653,019

Share it on Social Media